Difficulty: Medium
Average Score: 83%
Practice
A 52-year-old patient is taking well adjusted dosages of theophylline, warfarin, quinidine, and phenytoin for multiple medical problems. However, he starts taking a drug for some GI distress, but he presents with toxic effects from all his other medications, with elevation of their serum concentrations. Which was the drug the patient most likely took?
Correct answer
A
Rationale
In this scenario, the correct answer is A) Cimetidine. Cimetidine is a known inhibitor of the cytochrome P450 enzyme system in the liver, which is responsible for metabolizing many drugs, including theophylline, warfarin, quinidine, and phenytoin. By inhibiting this enzyme system, cimetidine can lead to increased serum concentrations of these medications, causing toxic effects.
Now, let's discuss why the other options are incorrect:
- B) Sucralfate: Sucralfate does not have a significant interaction with the cytochrome P450 system and is less likely to cause the observed toxic effects.
- C) Famotidine: Famotidine is not known to significantly interact with the cytochrome P450 system and is less likely to cause the observed toxic effects.
- D) Nizatidine: Similar to famotidine, nizatidine is not a potent inhibitor of the cytochrome P450 system and is less likely to cause the observed toxic effects.
From an educational perspective, this scenario highlights the importance of understanding drug-drug interactions, particularly with medications that can inhibit or induce cytochrome P450 enzymes. Healthcare providers should be aware of potential interactions when prescribing medications to patients who are already taking multiple drugs to prevent adverse effects and ensure patient safety.
Now, let's discuss why the other options are incorrect:
- B) Sucralfate: Sucralfate does not have a significant interaction with the cytochrome P450 system and is less likely to cause the observed toxic effects.
- C) Famotidine: Famotidine is not known to significantly interact with the cytochrome P450 system and is less likely to cause the observed toxic effects.
- D) Nizatidine: Similar to famotidine, nizatidine is not a potent inhibitor of the cytochrome P450 system and is less likely to cause the observed toxic effects.
From an educational perspective, this scenario highlights the importance of understanding drug-drug interactions, particularly with medications that can inhibit or induce cytochrome P450 enzymes. Healthcare providers should be aware of potential interactions when prescribing medications to patients who are already taking multiple drugs to prevent adverse effects and ensure patient safety.